Number of the records: 1
Deferoxamine derivatives as medicaments
- 1.
SYSNO ASEP 0557146 Document Type P - Patent R&D Document Type Patent or other outcome protected by special legislation Title Deferoxamine derivatives as medicaments Author(s) Truksa, Jaroslav (BTO-N) RID, ORCID
Werner, Lukáš (BTO-N)
Štursa, Jan (BTO-N)Year of issue 2021 Possible third party use of the result A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence Royalty requested A - Poskytovatel licence požaduje licenční poplatek Patent no. or utility model no. or industrial design no. EP 3655414 Date of the patent acceptance 25.08.2021 Name of the patent owner BIOTECHNOLOGICKÝ ÚSTAV AV ČR, v. v. i. SMART BRAIN, s.r.o. Code of the issuer name EPO_1 - European Patent Office Munich, The Hague, Berlin, Vienna, Brusselshttp://www.epo.org/ Current use A - Pouze udělený (dosud nevyužívaný) patent nebo patent využívaný jeho vlastníkem Language eng - English Keywords Iron ; Cancer ; Mitochondria Subject RIV EB - Genetics ; Molecular Biology OECD category Biochemistry and molecular biology Institutional support BTO-N - RVO:86652036 Annotation The deferoxamine derivatives of general formula I and pharmaceutically acceptable salts thereof, at least one of R1 and R2 is a substituent of formula II. The novel derivatives are particularly suitable as medicaments, preferably for the treatment of cancer. Pharmaceutical preparations of compounds of formula I and a metal, preferably gallium, are also provided resulting in even more active medicaments or contrast agents. Combinations with other agents, resulting in synergistic effects are provided. Workplace Institute of Biotechnology Contact Monika Kopřivová, Monika.Koprivova@ibt.cas.cz, Tel.: 325 873 700 Year of Publishing 2022 Electronic address https://worldwide.espacenet.com/patent/search/family/059363022/publication/EP3655414B1?q=pn%3DEP3655414B1
Number of the records: 1